L
Lorenzo Colarossi
Researcher at George Mason University
Publications - 15
Citations - 183
Lorenzo Colarossi is an academic researcher from George Mason University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 3, co-authored 15 publications receiving 40 citations.
Papers
More filters
Journal ArticleDOI
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
Simone Di Franco,Paola Bianca,Davide Stefano Sardina,Alice Turdo,Miriam Gaggianesi,Veronica Veschi,Annalisa Nicotra,Laura Rosa Mangiapane,Melania Lo Iacono,Irene Pillitteri,Sander R. van Hooff,Federica Martorana,Gianmarco Motta,Eliana Gulotta,Vincenzo Luca Lentini,Emanuele Martorana,Micol E. Fiori,Salvatore Vieni,Maria Rita Bongiorno,Giorgio Giannone,Dario Giuffrida,Lorenzo Memeo,Lorenzo Colarossi,Marzia Mare,Paolo Vigneri,Matilde Todaro,Ruggero De Maria,Jan Paul Medema,Giorgio Stassi +28 more
TL;DR: In this article, the authors show that visceral adipose derived factors promote vasculogenesis and metastatic dissemination by activation of STAT3, which inhibits miR-200a and enhances ZEB2 expression, effectively reprogramming colorectal cancer cells into a highly metastatic phenotype.
Journal ArticleDOI
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin.
Simone Di Franco,Barbara Parrino,Miriam Gaggianesi,Vincenzo Davide Pantina,Paola Bianca,Annalisa Nicotra,Laura Rosa Mangiapane,Melania Lo Iacono,Gloria Ganduscio,Veronica Veschi,Ornella Roberta Brancato,Antonino Glaviano,Alice Turdo,Irene Pillitteri,Lorenzo Colarossi,Stella Cascioferro,Daniela Carbone,Camilla Pecoraro,Micol E. Fiori,Ruggero De Maria,Matilde Todaro,Isabella Screpanti,Girolamo Cirrincione,Patrizia Diana,Giorgio Stassi +24 more
TL;DR: In this paper, the authors reported that exposure to a neo-synthetic bis(indolyl)thiazole alkaloid analog, nortopsentin 234 (NORA234), leads to an initial reduction of proliferative and clonogenic potential of CRC sphere cells, followed by an adaptive response selecting the CR-CSphC-resistant compartment.
Journal ArticleDOI
Role of Calixarene in Chemotherapy Delivery Strategies.
Rossella Basilotta,Deborah Mannino,Alessia Filippone,Giovanna Casili,Angela Prestifilippo,Lorenzo Colarossi,Gabriele Raciti,Emanuela Esposito,Michela Campolo +8 more
TL;DR: In this article, a review summarizes the numerous research advances regarding the development of calixarene nanoparticles capable of encapsulating various anticancer drugs in a controlled way, and shows that the use of these drugs as carriers of cancer drugs could reduce their side effects and increase their affinity towards the target.
Journal ArticleDOI
Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells
Lorenzo Colarossi,Lorenzo Memeo,Cristina Colarossi,Eleonora Aiello,Antonio Iuppa,Virginia Espina,Lance A. Liotta,Claudius Mueller +7 more
TL;DR: This work has investigated class IIa HDAC expression and inhibition in gastric cancer cells and found no significant differences between the three classes of HDACs studied.
Journal ArticleDOI
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment.
Miriam Gaggianesi,Simone Di Franco,Vincenzo Davide Pantina,Gaetana Porcelli,Caterina D’Accardo,Francesco Verona,Veronica Veschi,Lorenzo Colarossi,Naida Faldetta,Giuseppe Pistone,Maria Rita Bongiorno,Matilde Todaro,Giorgio Stassi +12 more
TL;DR: In this paper, a combinatorial approach was proposed to perturb the interaction network between CSCs and the different component of TME, which strengthened CSC refractoriness to standard and targeted therapies by enhancing survival signaling pathways, DNA repair machinery, expression of drug efflux transporters and anti-apoptotic proteins.